Upstream Share Discussion Threads

[master rsi] 25/7/2024 15:57

De La Rue shares fall as it warns on debt falling due next year

(Alliance News) - Shares in De La Rue PLC fell sharply on Thursday, as the banknote printer's reference to a "material uncertainty" overshadowed its annual results.

De La Rue shares were down 7.8% to 94.54 pence in London on Thursday afternoon. The stock was down as far at 88.40p in late-morning trade.

Basingstoke, Hampshire-based De La Rue provides Authentication software and Currency printing services.

Revenue fell 11% to GBP310.3 million in the financial year that ended March 30 from GBP349.7 million the year before. Pretax loss, however, slimmed to GBP15.4 million from GBP29.6 million, thanks to fewer exceptional charges.

Adjusted operating profit was GBP21.0 million, down from GBP27.8 million a year before. De La Rue noted this was in line with guidance it provided at the start of the year.

Net debt on March 30 was GBP89.4 million, up from a restated GBP82.4 million a year before, but slightly better than guidance of GBP90 million given back in December.

Looking ahead, De La Rue warned that its current cash flow forecasts suggest it will not have enough in its coffers to repay a revolving credit facility by the start of next July.

"Various strategic options are being pursued which would allow the group to repay the RCF on or before 1 July 2025

[master rsi] 25/7/2024 15:30

IHC 23p (4.00 / 21.05% - Inspiration Healthcare wins USD4.3 million order for neonatal devices

(Alliance News) - Inspiration Healthcare Group PLC on Thursday secured its largest single order for neonatal ventilators, following a long period of negotiations.

The Croydon, England-based healthcare technology company said it signed a USD4.3 million contract for the delivery of neonatal intensive care medical devices.

Included in the order are SLE6000 neonatal ventilators, First Breath respiratory support devices, and associated accessories.

Chair & Interim Chief Executive Officer Roy Davis said: "This is the largest single order we have executed for our SLE6000 ventilators and was previously delayed so that we could agree commercial terms and ensure the foundations for a long-term relationship were in place. We are confident of swifter and more streamlined negotiations on future potential orders."

[master rsi] 25/7/2024 14:39

DOW

Opening 7 points higher

[master rsi] 25/7/2024 13:57

Centamin stock slips despite revenue and production in first half
(Alliance News) - Centamin PLC on Thursday announced an increased interim dividend and backed its full-year guidance for gold production.

Shares in Centamin traded 6.0% lower at 121.60 pence in London on Thursday afternoon.

The operator of the Sukari gold mine in Egypt said that for the first half of 2024, gold production rose 1.9% annually to 224,738 ounces from 220,562 ounces.

Pretax profit was USD117.1 million, up 2.0% from USD114.8 million, but basic earnings per share fell 9% to USD7.19 from USD7.86. Adjusted earnings before interest, tax, depreciation and amortisation was USD210.7 million, up 9.3% from USD192.9 million.

Revenue increased 8.5% to USD465.1 million from USD425.6 million. However gold sales decreased 4.6% to 209,269 ounces from 219,354

ounces.

Centamin declared an interim dividend of 2.25 US cents per share, "exceeding the minimum policy of distributing 30% of cash flow available for dividends", up from 2.0 cents.

Looking ahead, Centamin maintained its full-year guidance including between 470,000 and 500,000 ounces of gold produced per year. It expects this to be weighted towards the second half, and to mark an increase from the 450,058 ounces produced in 2023.

"Our focus on operating performance has enabled us to take advantage of stronger gold prices to deliver improved Ebitda and a significant increase in free cash flow," commented Chief Executive Officer Martin Horgan. "Looking ahead to H2 2024, the commencement of the grid connection project will build on our recent success in taking costs out of the business, with commissioning due in H1 2025.

"At the same time, we are advancing the organic growth opportunities within our portfolio. The completion of the [definitive feasibility study] at Doropo shows a very robust project; we are now well positioned to apply for a mining licence which we expect should be granted by the end of 2024, ahead of a final investment decision."

Last week, Centamin released a definitive feasibility study for the Doropo gold project in Ivory Coast, saying it demonstrates a "robust project" that meets its investment criteria. The DFS estimated probable mineral reserves of 1.88 million ounces of gold at an average grade of 1.53 grammes of gold per tonne of ore. This supports a 10-year life of mine, Centamin said, with average annual gold production of 167,000 ounces.

CEO Horgan added: "Meanwhile, we are aggressively following up on the recent success at our Eastern Desert exploration project with the continued drill out of the Little Sukari discovery."

[master rsi] 25/7/2024 12:43

MARKET REPORT
LONDON MARKET MIDDAY: Drab earnings unnerve equities before US data

(Alliance News) - European equities tumbled on Thursday, with tepid earnings causing a sea of red across major benchmarks, compounding already fragile sentiment after a sell-off in New York.

The FTSE 100 index traded down 59.21 points, or 0.7%, at 8,094.48. The FTSE 250 was down 224.81 points, 1.1%, at 20,726.03, while the AIM All-Share fell 7.50 points, 1.0%, at 769.14.

The Cboe UK 100 was down 0.7% at 807.67, the Cboe UK 250 dropped 1.2% to 18,129.36, and the Cboe Small Companies plunged 1.6% to 16,945.16.

The CAC 40 in Paris slumped 2.2%, while Frankfurt's DAX 40 traded 1.4% lower. The CAC 40 sat at around 7,347.08, putting it around 10% below its May 15 closing peak. Should it close at this current level, it will technically be in correction territory.

In New York, the Dow Jones Industrial Average is called to open 0.1% lower, the S&P 500 down 0.3% and the Nasdaq Composite down 0.5%. The benchmarks had tumbled on Wednesday.

Shares in Europe fell under the weight of poorly-received earnings. There were guidance cuts, profit falls and sales declines for investors to contend with. But even those that managed to improve their top- and bottom-lines and up guidance struggled too, suggesting the bar is high during this corporate earnings season.

One stock that fell victim to good not being "good enough", XTB analyst Kathleen Brooks said, was AstraZeneca.

"The market is scrutinizing earnings reports and punishing pockets of weakness," Brooks added, as the analyst said higher than expected costs may have been behind the 3.3% fall in the company's shares.

The Cambridge-based pharmaceutical firm said total revenue in the first half of 2024 surged 15% to USD25.62 billion from USD22.30 billion. Pretax profit jumped 19% to USD5.29 billion from USD4.35 billion.

For the second-quarter alone, revenue climbed 13% USD12.94 billion, and pretax profit was 15% higher at USD2.40 billion.

Looking to the full-year, the pharmaceutical firm now expects total revenue and core EPS to grow by a "mid teens percentage" at constant currency, its view upgraded from a previously expected "low double-digit to low teens rise".

Besides AstraZeneca, the pharmaceutical sector was a space that was somewhat spared from Thursday's sell-off. Sanofi rose 4.1% in Paris and Roche up 2.3% in Zurich, rare bits of green among the shares of European blue-chips that reported earnings on Thursday morning.

The automotive sector suffered, with Fiat owner Stellantis tumbling 8.8% after a first-half that it admitted "fell short".

A poor period for luxury retail continued, with this time Gucci owner Kering at the heart of the sell-off, down 7.3% in Paris, while even the music sector provided a bum note, as Universal Music Group plunged 26% in Amsterdam after its earnings.

UMG dragged London-listed Pershing Square Holdings down with it. The firm, managed by Bill Ackman's Pershing Square Capital Management, is a UMG investor.

Consumer goods firm Unilever and tobacco company BAT provided bright spots for the FTSE 100, up 6.6% and 4.6%.

Unilever upped its margin target. It now expects its full-year underlying operating margin "to be at least 18%". It had previously predicted a "modest improvement" from the 16.7% achieved in 2023.

BAT said its first-half performance for 2024 was in line with its expectations, and indicated that it is on track to deliver its full-year guidance.

The London-based cigarette and vaping products maker reported a 5.7% rise in pretax profit to GBP5.60 billion for the first half of 2024 from GBP5.30 billion a year earlier, boosted by profit from "associates and joint ventures".

But revenue fell 8.2% to GBP12.34 billion from GBP13.44 billion, driven by the sale of businesses in Russia and Belarus in September 2023, and currency headwinds.

For 2024, the company guides for low-single figure organic constant currency revenue growth and also low-single figure organic adjusted profit from operations growth.

Elsewhere in London, banknote printer De La Rue plunged 15%, as the reference to a "material uncertainty" overshadowed its annual results.

Revenue in the year to March 25 fell 11% to GBP310.3 million from GBP349.7 million. Its pretax loss, however, slimmed to GBP15.4 million from GBP29.6 million.

Looking ahead, it warned that its current cash flow forecasts suggest it will not have enough in its coffers to repay a revolving credit facility by the start of next July.

"Various strategic options are being pursued which would allow the group to repay the RCF on or before 1 July 2025. The most progressed of those is the sale of the Authentication division. The board notes that the probability of completion, timing and terms of the sale of the division are subject to factors outside of the board's control, which may in turn impact the cash proceeds, the costs associated with the transaction and the amounts required to address any pension scheme risk, along with the day one liquidity of the retained operations of the group. These matters represent a material uncertainty which may cast significant doubt upon the group's ability and the company's ability to continue as a going concern for a period up to 28 September 2025," De La Rue cautioned.

Brent oil was quoted at USD80.43 a barrel early on Thursday afternoon, falling from USD81.75 at the time of the London equities close Wednesday. Gold was quoted at USD2,378.13 an ounce, down from USD2,426.06.

Still to come on Thursday is a US gross domestic product reading and a quarterly personal consumption expenditures reading at 1330 BST. The latest monthly PCE gauge is due on Friday, amid a backdrop of dwindling Federal Reserve interest rate expectations.

ING analysts commented: "The focus will be on the second quarter GDP figure. This is expected to rise to 2.0% quarter-on-quarter annualised from 1.4% in the first quarter. More interest might be had in the second quarter core PCE price data. From this investors will be able to calculate tomorrow's release of the June core PCE number. That number is widely expected at 0.2% month-on-month, consistent with the Fed's 2% inflation target. Confirmation of such a number could see the short end of the US yield curve drop further as the market shifts to pricing in three rate cuts this year. Currently, the market fully prices a 25bp Fed cut in September and 63bp of cuts in total for this year."

The pound was quoted at USD1.2872 early on Thursday afternoon, down from USD1.2926 at the time of the London equities close Wednesday. The euro stood at USD1.0850, fading from USD1.0857. Against the yen, the dollar was trading at JPY152.23, down from JPY153.44.

[master rsi] 25/7/2024 12:25

How the UPS are performing during last month

[master rsi] 25/7/2024 12:06

How the UPS are performing today

[master rsi] 25/7/2024 11:22

SMALL-CAP WINNERS & LOSERS: Upland bullish on Sarawak; CAB slumps
SMALL-CAP - WINNERS

Upland Resources Ltd, up 22% at 1.25 pence, 12-month range 0.66p-8.98p. It confirms it has been in talks with the Sarawak state government in Malaysia as it bids to get an interest in a production sharing contract for Block SK334. Earlier this week, Upland noted Petroleum Sarawak Bhd, or Petros, is planning technical work on the onshore exploration block to enable Petros to offer the asset for competitive bidding to all interested investors. "In the terms and conditions of the signed joint technical study agreement between Upland and Petros, and as a medium-term strategy, Upland has certain unique advantages over other potential bidders in a competitive bidding process," Upland says on Thursday.


SMALL-CAP - LOSERS

CAB Payments Holdings PLC, down 13% at 88.26 pence, 12-month range 46.10p-307.50p. The London-based payment processing and foreign exchange company expects to report a 22% decline in gross income over the first half. Excluding dislocations in Nigerian naira and central bank interventions in the Central African and West African francs, however, it will rise 11%. "The business is now on a more balanced trajectory with 2023 proving to be an exceptional year. The group also believes that in 2024 there are no significant tailwinds in its major corridors. As a result, the group expects total gross income for 2024 to be marginally down compared to last year," CAB predicts. The firm listed in July of last year and shares sit 74% off the GBP3.35 initial public offering price.

----------

Bloomsbury Publishing PLC, down 2.3% at 684.00 pence, 12-month range 365.00p-726.00p. Shares in the publishing company fall as it goes ex-dividend, meaning new buyers do not qualify for the latest payout.

[master rsi] 25/7/2024 10:33

LONDON BROKER RATINGS: Barclays and Berenberg cut Ascential
FTSE 100

Goldman Sachs raises Rentokil Initial price target to 570 (550) pence - 'neutral'

UBS raises Informa price target to 1,055 (1,040) pence - 'buy'

Barclays raises Informa price target to 1,010 (980) pence - 'overweight'

UBS cuts Prudential price target to 1,090 (1,110) pence - 'buy'

Goldman Sachs raises Unilever price target to 5,040 (4,590) pence - 'neutral'

Berenberg raises Reckitt Benckiser price target to 5,200 (5,100) pence - 'hold'

RBC raises Reckitt Benckiser price target to 5,200 (5,100) pence - 'outperform'

RBC cuts easyJet price target to 550 (580) pence - 'sector perform

Barclays cuts easyJet price target to 675 (700) pence - 'overweight'

UBS cuts easyJet price target to 785 (850) pence - 'buy'

Bank of America cuts easyJet price target to 670 (740) pence - 'buy'



FTSE 250

UBS raises Breedon to 'buy' (neutral) - price target 460 (420) pence

Berenberg cuts RHI Magnesita price target to 4,150 (4,300) pence - 'buy'

Berenberg cuts Ascential to 'hold' (buy) - price target 568 (395) pence

Barclays cuts Ascential to 'equal weight' (overweight) - price target 570 (375) pence

Deutsche Bank cuts Primary Health to hold (buy) - price target 103 (110) pence

Berenberg raises Spectris to 'buy' (hold) - price target 3,920 (3,520) pence

HSBC cuts RS Group to 'hold' - price target 810 pence

Jefferies raises Bridgepoint price target to 320 (310) pence - 'buy'


SMALL CAP

Deutsche Bank cuts Learning Technologies price target to 131 (149) pence - buy

Jefferies raises PensionBee price target to 211 (172) pence - 'buy'

Berenberg raises PensionBee price target to 210 (170) pence - 'buy'

[master rsi] 25/7/2024 09:30

MARKET REPORT
LONDON MARKET OPEN: Earnings woe sends European stocks lower

(Alliance News) - Stock prices in London opened lower on Thursday, with earnings from the UK and beyond largely falling short, after sentiment was already hurt by a tech sell-off in New York.

Still, the FTSE 100 index traded down 60.56 points, or 0.7%, at 8,093.13. The FTSE 250 was down 201.65 points, 1.0%, at 20,749.19, while the AIM All-Share fell 5.35 points, 0.7%, at 771.29.

The Cboe UK 100 was down 0.7% at 807.72, the Cboe UK 250 dropped 1.1% to 18,155.80, and the Cboe Small Companies fell 0.1% to 17,207.02.

The CAC 40 in Paris slumped 1.4%, while Frankfurt's DAX 40 traded 1.1% lower.

In New York on Wednesday, the Dow Jones Industrial Average ended down 1.3%, the S&P 500 fell 2.3% and the Nasdaq Composite plunged 3.6%.

In Asia on Thursday, the Nikkei 225 slumped 3.3%, while the S&P/ASX 200 in Sydney ended 1.3% lower. In China, the Shanghai Composite fell down 0.5%, while the Hang Seng was 1.6% lower.

Shares in Europe suffered in response to the morning's batch of earnings in Europe, as well as some updates from overnight.

Among those falling were food and drink company Nestle, down 4.5% in Zurich on a guidance cut.

Luxury retail continued to suffer, after Kering reported a poor half-year. That stock was down 7.6% in Paris.

Chipmaker STMicroelectronics plunged 11% in Paris as it cut its outlook.

The automotive story was also a drab one, with Stellantis down 9.0% in Milan and Renault down 8.1% in Paris. Further afield, a profit outlook cut from Nissan sent that stock 7.0% lower in Tokyo, while Ford had plunged 12% after hours in New York.

Over in Sydney, the theme of tepid earnings was also evident, as Macquarie fell 3.4% on a poorly-received first-quarter update.

Trade was more resilient in the healthcare sector. Roche upped guidance and shares were rewarded with a 3.3% rise in Zurich. Sanofi also upped its outlook, and it traded 3.9% higher in Paris.

In London, AstraZeneca improved its full-year view, though shares fell 2.3%.

Total revenue in the first-half of 2024 surged 15% to USD25.62 billion from USD22.30 billion. Pretax profit jumped 19% to USD5.29 billion from USD4.35 billion. For the second-quarter alone, revenue climbed 13% USD12.94 billion, and pretax profit was 15% higher at USD2.40 billion.

Looking to the full-year, it now expects total revenue to grow by a "mid teens percentage" at constant currency, its view upgraded from a previously expects "low double-digit to low teens rise".

Unilever rose 6.5% as it backed its outlook. The consumer goods firm reported a rise in revenue and profit in the first-half. Revenue in the first six months of 2024 climbed 2.3% to EUR31.12 billion from EUR30.43 billion. Pretax profit increased 5.7% to EUR5.57 billion from EUR5.27 billion.

Underlying sales growth for the half-year was 4.1%, helped by a 2.6% rise in margins and a 1.6% pricing increase.

"We continue to expect underlying sales growth for 2024 to be within our multi-year range of 3% to 5%, with the majority of the growth being driven by volume," the firm behind brands such as Dove and Cif said.

Elsewhere in London, ITV fell 5.1% as it cut guidance at its ITV Studios production arm.

The firm now expects revenue for the ITV Studios production arm to "be down low single digits" for the full-year. It had previously expected it to be "broadly flat". The downgrade is due to a "small number of key productions being contracted as executive productions rather than co-productions".

"The change in contractual arrangement has no impact on profit but does mean we recognise less revenue this year. There remain a small number of contracts under negotiation, which may have a similar out-turn of lower recognised revenue, but the same profit if they are contracted as executive productions. In the revenue guidance for 2024, we have assumed that we will be the main or co-producer," the firm said.

Indivior shot up 16%, easing some recent share price pressure on the stock, as it maintained its recently lowered outlook and announced a share buyback.

The specialty pharmaceuticals business said revenue in the first-half of the year improved 10% to USD583 million from USD529 million. It swung to a pretax loss, however, of USD72 million from profit of USD120 million.

Its second-quarter revenue rose 8.3% to USD299 million from USD276 million, but it posted a loss of USD135 million, swinging from profit of USD62 million.

Selling, general, and administrative expenses in the quarter jumped to USD311 million from USD133 million. The figure includes costs related to a legal settlement, its US primary listing and the hit from the discontinuation of schizophrenia drug Perseris, announced earlier in July.

"While 2024 has proved to be a more challenging year than we had anticipated, we remain highly confident in the underlying fundamentals of our business and strategy, and that we are on a clear path to create substantial shareholder value. Reflecting our confidence, we are today announcing a new USD100 million share repurchase programme which we intend to execute over an accelerated time frame," CEO Mark Crossley said.

The pound was quoted at USD1.2881 early on Thursday, down from USD1.2926 at the time of the London equities close Wednesday. The euro stood at USD1.0840, fading from USD1.0857. Against the yen, the dollar was trading at JPY152.22, down from JPY153.44.

China's central bank on Thursday unexpectedly cut a medium-term interest rate by the most in more than four years, marking the latest move by authorities to boost economic growth.

The world's second-largest economy has encountered severe headwinds in recent years, as a heavily indebted property sector, sluggish consumption and high youth unemployment weigh on confidence.

Beijing has introduced a host of measures in recent months in a bid to get it humming again, but a full rebound has so far proven elusive.

In a surprise move on Thursday morning, the People's Bank of China slashed the rate for its medium-term lending facility – the interest on one-year loans to financial institutions – to 2.3%, from 2.5%.

The central bank typically makes MLF announcements on a predetermined day in the middle of the month.

The last time the rate was cut was in August, but the latest is the biggest since April 2020.

Brent oil was quoted at USD81.00 a barrel early on Thursday, falling from USD81.75. Gold was quoted at USD2,375.34 an ounce, down from USD2,426.06.

Still to come on Thursday is a US gross domestic product reading at 1330 BST.

[master rsi] 25/7/2024 09:09

Centrica profits tumble but dividend up and buyback extended

Centrica’s profits tumbled in its latest as gas prices normalised and the bumper profits it made from the energy cap washed through.

Striping those exceptional gains out profits still halved to £1 billion (£2.1bn), but the British Gas owner upped its interim dividend by 13% to 1.5p and extended its share buyback by £200 million cash balances rose to £3.2 billion.

Underlying profits at British Gas dropped 84% even though customer numbers stayed flat at around 7.48 million.

Another weak area currently is the Rough storage facility, though the residential services are doing better and continue to recover.

Chris O’Shea, chief executive, said the results reflected the more normalised conditions in the energy market.

Results this year will be heavily first-half weighted, he added. with cash holdings to decline as capital expenditure ramps up and dividends are paid out.

[master rsi] 25/7/2024 08:44

In Commodities Trading:

Gold Futures for August delivery declined 48.35 points to 2,367.35 a troy ounce.
Crude Oil for September delivery fell 0.63 points to 76.96 a barrel.
September Brent Oil Contract dropped 0.75% or 0.61 points to 81.10 a barrel.

Currency Markets:
GBP/USD is back in to 1.28 territory after testing over 1.29 yesterday with the daily range between 1.2874-1.2917.
EUR/GBP is stable at 0.84.
The US Dollar Index Futures was down 0.04% at 104.077

[master rsi] 25/7/2024 08:29

FTSE

The market was marked down heavily with 72 points and FTSE 250 was much the same with 198 points lower. .....

U.K. equities started with losses on Thursday, with falls in majority of sectors, the most notable ones being the Mining, Electricity, Mobile Telecommunications, Support Services and Industrial Transportation.

At the market open in London, the FTSE 100 Index dropped 0.74%. The FTSE 250 Index and the FTSE 350 Index also declined. The FTSE 250 fell 0.71%, while the FTSE 350 was down by 0.83%.

Top Gainers:
Unilever (LON:ULVR): Climbed 6.28% or 276.0 points to 4,673.0
HALEON (LON:HLN): Rose 2.33% or 7.90 points to 347.60
GSK (LON:GSK) plc: Increased 0.50% or 7.50 points to 1,517.50

Top Losers:
Centrica (LON:CNA): Declined 8.91% or 12.75 points to 130.13
Rentokil (LON:RTO): Dropped 5.76% or 27.30 points to 446.40
Airtel Africa (LON:AAF): Fell 5.56% or 6.39 points to 108.60

[apotheki] 25/7/2024 08:05

AFENTRA PLC / LSE:AET

Award of KON 19 License Onshore Angola


Afentra plc ('Afentra' or the 'Company') (AIM: AET), the upstream oil and gas company focused on acquiring production and development assets in Africa, advises that, further to the announcement on 10 July confirming the award by Presidential Decree of the onshore Angola license KON 19, the formal award of KON 19 was signed yesterday with the Agência Nacional de Petróleo, Gás e Biocombustíveis (ANPG).

Afentra has been assigned a 45% non-operated interest in KON 19 alongside two local Angolan companies ACREP and Enagol. The equity participation in the license is:

Block KON 19 Ownership Interests

Status
Name
Interest
Operator
ACREP
45%
Non-Operator
Afentra
45%
Enagol
10%

Contract discussions on Block KON 15 are ongoing and continue to make progress.

The onshore Kwanza basin, covering 25,000 Sqkm, is an under-exploited and overlooked proven hydrocarbon basin with numerous oil fields and discoveries dating back to 1955. Both KON15 and KON19 blocks are high-graded by Afentra as they have good signs of a working petroleum system. The blocks are adjacent to both legacy oil fields that are currently being appraised for potential re-development and existing infrastructure allowing rapid commercialisation.

Commenting on the update, CEO Paul McDade said:

"We are very pleased to have been formally awarded this new license, which further enhances our strategic position in Angola. The license expands Afentra's footprint in this attractive market and further diversifies our portfolio with a low-cost onshore block with significant potential. We look forward to bringing our technical expertise in support of our local Angolan Operator as we collaborate to define the full potential of this license. We will update the market fully on our onshore strategy and work program upon completion of the onshore award process."

[master rsi] 24/7/2024 23:23

Thursday's UK corporate calendar,

There are half-year results from Anglo American, AstraZeneca, British American Tobacco, Lloyds Banking Group, Relx, Rentokil Initial and Vodafone.

Trading updates are expected from BT and Vodafone

[master rsi] 24/7/2024 22:54

v
Jubilee Metals revealed on Wednesday that chief executive officer Leon Coetzer had acquired 625,000 ordinary shares in the Africa-focussed metals processor.

Coetzer, who took over as CEO in 2017, purchased the shares at an average price of 6.40p, for a total value of £40,000.

Following the transaction, Coetzer holds a beneficial interest in 1.42m ordinary Jubilee shares, representing approximately 0.047% of the company's issued share capital.

Top Director Buys

Jubilee Metals Group (JLP)

Director name: Coetzer,Leon

Amount purchased: 625,000 @ 6.40p

Value: £40,000.00

Bluefield Solar Income Fund Limited (BSIF)

Director name: Lenfestey,Meriel

Amount purchased: 12,307 @ 107.33p

Value: £13,208.99

Audioboom Group (BOOM)

Director name: Tobin,Michael

Amount purchased: 4,000 @ 226.00p

Value: £9,040.00

(OHT)

Director name: Walker,Stephen

Amount purchased: 45,000 @ 8.40p

Value: £3,780.00

Gunsynd (GUN)

Director name: Strang,Donald

Amount purchased: 1,000,000 @ 0.12p

Value: £1,215.00



Top Director Sells

Wise Class A (WISE)

Director name: Wells,David

Amount sold: 223,000 @ 787.08p

Value: £1,755,183.30

(PRE)

Director name: Atherley,Paul Campbell

Amount sold: 1,435,000 @ 16.70p

Value: £239,644.99

Halma (HLMA)

Director name: Ronchetti,Marc

Amount sold: 6,958 @ 2,611.00p

Value: £181,673.38

Cmc Markets (CMCX)

Director name: Fineberg,David

Amount sold: 51,770 @ 311.75p

Value: £161,392.98

Halma (HLMA)

Director name: Ward,Jennifer

Amount sold: 3,986 @ 2,611.00p

Value: £104,074.46

Cmc Markets (CMCX)

Director name: Lewis,Matthew

Amount sold: 25,863 @ 311.75p

Value: £80,627.90

S4 Capital (SFOR)

Director name: Basterfield,Mary

Amount sold: 36,295 @ 52.94p

Value: £19,214.57

(PRE)

Director name: Atherley,Paul Campbell

Amount sold: 65,000 @ 18.00p

Value: £11,700.00

[master rsi] 24/7/2024 22:02

DOW

Well down at the end of the day with 504 points lower ......

Wall Street stocks closed sharply lower on Wednesday after investors got their first taste of Q2 big tech earnings overnight and thumbed over a number of data points.

At the close, the Dow Jones Industrial Average was down 1.25% at 39,853.87,
while the S&P 500 lost 2.31% to 5,427.13
and the Nasdaq Composite saw out the session 3.64% lower at 17,342.41.

[master rsi] 24/7/2024 16:45

How the UPS are performing during last month

[master rsi] 24/7/2024 16:31

How the UPS are performing today

[master rsi] 24/7/2024 16:12

GOLD +$21 and SILVER are motoring and COPPER recovering from the early drop.

Intraday ---- Gold -------------- Silver ---------------- Copper -----


1 month ----- Gold ---------------- Silver --------------- Copper -----